EOPatch X, Wearable Artificial Pancreas by iQflow, Selected for MFDS 'Pan-Government R&D Coordination' Project

[Asia Economy Reporter Hyunseok Yoo] IoFlow announced on the 16th that its sensor-detachable wearable artificial pancreas, ‘IoPatch X,’ has been selected for the Ministry of Food and Drug Safety’s ‘Pan-Government R&D Coordination’ project.

The ‘Pan-Government R&D Coordination’ program is operated by the Ministry of Food and Drug Safety in collaboration with the Pan-Government Full-Cycle Medical Device R&D Consortium (hereafter Pan-Government Consortium) to expedite the commercialization of medical devices. Among the projects of the Pan-Government Consortium, those with potential for early commercialization are evaluated and selected for priority support, followed by close assistance through each stage from product development to market launch.

With this project selection, IoFlow will receive administrative and technical support from designated officials within the Ministry of Food and Drug Safety throughout the entire cycle for ‘IoPatch X,’ including research and development stages, clinical trial plan approval, manufacturing and quality control (GMP), safety and performance evaluation, manufacturing authorization, overseas certification, and export support.

‘IoPatch X’ was previously selected last year for the Pan-Government Consortium’s full-cycle medical device R&D project and is currently progressing with the goal of obtaining final product approval from the Ministry of Food and Drug Safety.

Seo Jongok, Head of Marketing at IoFlow, stated, “As IoFlow’s sensor-detachable wearable artificial pancreas is a globally leading product with no domestic or international commercialization cases yet, it is essential to proceed swiftly not only with research and development but also with product commercialization and market entry. To this end, a collaborative system with related organizations is necessary, and through this project, we will receive close support, bringing product commercialization closer.”

IoFlow’s sensor-detachable wearable artificial pancreas, ‘IoPatch X,’ integrates a continuous glucose monitoring system and an artificial pancreas algorithm with the wearable insulin pump product ‘IoPatch.’ It automatically injects insulin according to the user’s blood glucose levels, minimizing the process where users measure blood glucose and calculate insulin doses themselves.

This content was produced with the assistance of AI translation services.